The main driver mutation in melanoma is BRAFV600E, and the downregulation of phosphatase tensin homolog (PTEN) leads to deregulation of key signaling pathways that also lead to enhanced expression of anti-apoptotic proteins [6,7,8,9]. The gene discussed is PTEN; the disease is melanoma.